Health News Releases

  • Today April 22
February 23, 2022 16:40
rf IDEAS and Key Partners to Spotlight Healthcare IAM Solutions at HIMSS22
rf IDEAS, a global leader in the design and manufacture of credential readers for authentication and logical access, will be on site at the HIMSS22 Conference in Orlando, Florida (Booth #1313) with ke
February 23, 2022 11:43
Taro to Acquire Alchemee From Galderma
Galderma and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from G
February 23, 2022 10:50
Kaneka Eurogentec Announces the Successful Production of 25g of mRNA in One Batch
Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization (CDMO), announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for
February 23, 2022 10:00
Laboratory Information Systems Market is slated to increase at a CAGR of 10.2% to reach a valuation of USD 4.2 Billion by 2030: Future Market Insights
Global laboratory information system (LIS) market revenues are set to grow at 10.2% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2022-2030 version of the rep
February 22, 2022 16:00
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”) today announced the results from an analysis of a total of 37 individuals enrolled in its Evaluation and Assessment o
February 22, 2022 15:54
Advanced Wound Management Market is projected to grow at a steady pace, exceeding a market valuation of USD 6.5 Billion between 2021 and 2031: Future Market Insights
Growing investments in the healthcare sector, coupled with innovations in advanced wound management products are anticipated to positively shape demand in the upcoming years. With an increasing inc
February 21, 2022 11:55
European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations
Merck, a leading science and technology company, today announced that the European Commission (EC) has approved once-daily oral TEPMETKO® (tepotinib) as monotherapy for the treatment of adult patients
February 21, 2022 11:30
Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma
Merck, a leading science and technology company, today announced the results of an exploratory analysis from the Phase III JAVELIN Bladder 100 trial with 19 additional months of follow-up data from th
February 21, 2022 10:35
Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study[1,2]
Takeda (TSE:4502/NYSE:TAK) today announced the first six-month interim analysis results from INSPIRE, in which clinical remission[*] was observed in 65% of patients in both cohorts who were evaluated
February 18, 2022 16:28
Karen L. Ling joins Galderma’s Advisory Committee
Galderma, the world’s largest independent dermatology company, announced today that Karen L. Ling will join its Advisory Committee, effective March 1, 2022. Karen Ling has a tremendous track record
February 18, 2022 09:10
NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles
NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy. The co
February 17, 2022 15:20
Vifor Pharma reports sustained growth in 2021
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject®
February 17, 2022 11:40
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
Organon (NYSE: OGN) today announced that it has acquired the rights from Bayer AG to Marvelon® and Mercilon®, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, inclu
February 17, 2022 10:21
Capsa Healthcare Announces the Acquisition of Humanscale Healthcare
Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and
February 16, 2022 11:46
Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials
Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for c
BreastScreen Victoria Switches to Rimini Street Support for its Oracle Database Software, Unlocks Resources to Meet Increasing Service Demand
February 16, 2022 11:43
BreastScreen Victoria Switches to Rimini Street Support for its Oracle Database Software, Unlocks Resources to Meet Increasing Service Demand
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partn
February 16, 2022 10:03
German Federal Court of Justice Upholds AOP‘s License Rights in Ropeginterferon and PEC’s Liability for Damages.
Since 2017, PharmaEssentia had repeatedly attempted to terminate the agreement with AOP concerning BESREMi® (Ropeginterferon alfa-2b). In October 2020, after two and a half years of arbitral proceedin
February 15, 2022 10:30
Mawi DNA Technologies Awarded Two ISO Certifications
Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management
February 11, 2022 09:00
Vision Care Market is projected to account for over USD 127.73 Bn, in terms of value, by 2028 end: Future Market Insights
The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems has increased and so is th
February 09, 2022 16:15
Theramex Reinforces its Commitment to Women on International Women’s Day
International Women’s Day is an important date on the calendar to recognise and celebrate the social, economic, culture, political, scientific and many more achievements of women globally. At Theramex
February 09, 2022 13:55
Mandy Moore Partners With Lumenis to Raise Awareness of Dry Eye Disease and OptiLight Treatment
Lumenis today announced that it has partnered with singer-songwriter and actress Mandy Moore as a brand ambassador for OptiLight, a bright solution for dry eyes. Ms. Moore suffered from dry eye diseas
February 08, 2022 15:55
Cook Medical Reproductive Health Business to be Acquired by CooperCompanies
Cook Medical today announced it signed a letter of intent with CooperCompanies to sell the entirety of Cook’s Reproductive Health business within the MedSurg division. CooperCompanies (NYSE:COO), a pu
February 07, 2022 13:50
Takeda Delivers Strong Third Quarter FY2021 Results and Raises Full-Year Forecast Reflecting Strong Momentum
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the third quarter of its fiscal year 2021 (period ended December 31, 2021) driven by robust topline growth of its 14 global br
February 07, 2022 10:30
Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials
Medidata, a Dassault Systèmes company, announced today that Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance pa
February 04, 2022 16:00
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
Dr. Reddy‘s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a def
25 per page50 per page75 per page100 per page